Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTRUST1: Indacaterol + Tiotropium in COPD
NCT00846586Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of indacaterol in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Mar 2009; status: completed.
02
Drugs
indacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00846586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00846586.